Nov 20 2023
Recruiting Research Participants Diagnosed with Narcolepsy Type 2 or Idiopathic Hypersomnia
h in Clinical Trial
Past Opportunity – No Longer Seeking Participants
Biotrial is collaborating with Alkermes to recruit individuals diagnosed with narcolepsy type 2 or idiopathic hypersomnia (IH) to participate in a research study to assess the proof of concept, safety, and tolerability of an investigational study drug, an orexin-2 receptor agonist.
Do you want to participate in advancing medical research in narcolepsy and idiopathic hypersomnia (IH)?
You may qualify and be compensated up to $2,750 for participating in this study if you meet the following criteria:
- Males and females 18- 65 years old
- Diagnosed with narcolepsy type 2 (without cataplexy) or with idiopathic hypersomnia (IH)
- BMI between 18 and 45 (use the BMI calculator below)
- Non-smokers
- Additional criteria apply
Transportation and other means of support will be provided throughout the study.
Check-in dates: They will be set up according to the participant’s availability.
Do you want to know more about this study? Click here.
Do you want to participate? Contact Luz Stevens at 973-388-8448 or email luz.stevens@biotrial.us.
Share this study with a friend and earn up to $500 if your friend is eligible and participates.
For more information about the study, click here.